206 related articles for article (PubMed ID: 33863723)
21. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
Cai Z; Wang C; He W; Chen Y
Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
[TBL] [Abstract][Full Text] [Related]
22. Neuronal ApoE4 stimulates C/EBPβ activation, promoting Alzheimer's disease pathology in a mouse model.
Wang ZH; Xia Y; Wu Z; Kang SS; Zhang JC; Liu P; Liu X; Song W; Huin V; Dhaenens CM; Yu SP; Wang XC; Ye K
Prog Neurobiol; 2022 Feb; 209():102212. PubMed ID: 34958873
[TBL] [Abstract][Full Text] [Related]
23. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
[TBL] [Abstract][Full Text] [Related]
24. γ-Secretase complexes containing caspase-cleaved presenilin-1 increase intracellular Aβ(42) /Aβ(40) ratio.
Hedskog L; Petersen CA; Svensson AI; Welander H; Tjernberg LO; Karlström H; Ankarcrona M
J Cell Mol Med; 2011 Oct; 15(10):2150-63. PubMed ID: 21054783
[TBL] [Abstract][Full Text] [Related]
25. Delta-secretase cleavage of Tau mediates its pathology and propagation in Alzheimer's disease.
Kang SS; Ahn EH; Ye K
Exp Mol Med; 2020 Aug; 52(8):1275-1287. PubMed ID: 32859953
[TBL] [Abstract][Full Text] [Related]
26. Delta-secretase (AEP) mediates tau-splicing imbalance and accelerates cognitive decline in tauopathies.
Wang ZH; Liu P; Liu X; Yu SP; Wang JZ; Ye K
J Exp Med; 2018 Dec; 215(12):3038-3056. PubMed ID: 30373880
[TBL] [Abstract][Full Text] [Related]
27. Dynamic Nature of presenilin1/γ-Secretase: Implication for Alzheimer's Disease Pathogenesis.
Zoltowska KM; Berezovska O
Mol Neurobiol; 2018 Mar; 55(3):2275-2284. PubMed ID: 28332150
[TBL] [Abstract][Full Text] [Related]
28. BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis.
Zhang S; Wang Z; Cai F; Zhang M; Wu Y; Zhang J; Song W
J Neurosci; 2017 Jul; 37(29):6915-6925. PubMed ID: 28626014
[TBL] [Abstract][Full Text] [Related]
29. Alzheimer's disease and Notch signaling.
Woo HN; Park JS; Gwon AR; Arumugam TV; Jo DG
Biochem Biophys Res Commun; 2009 Dec; 390(4):1093-7. PubMed ID: 19853579
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic and genetic alterations in Netrin-1 receptors UNC5C and DCC in human colon cancer.
Shin SK; Nagasaka T; Jung BH; Matsubara N; Kim WH; Carethers JM; Boland CR; Goel A
Gastroenterology; 2007 Dec; 133(6):1849-57. PubMed ID: 18054557
[TBL] [Abstract][Full Text] [Related]
31. Different Expression Patterns of Amyloid-β Protein Precursor Secretases in Human and Mouse Hippocampal Neurons: A Potential Contribution to Species Differences in Neuronal Susceptibility to Amyloid-β Pathogenesis.
Xu ZQ; Huang H; Chen YL; Gao YY; Xu J; Marshall C; Cai ZY; Xiao M
J Alzheimers Dis; 2016; 51(1):179-95. PubMed ID: 26836155
[TBL] [Abstract][Full Text] [Related]
32. Oxidative lipid modification of nicastrin enhances amyloidogenic γ-secretase activity in Alzheimer's disease.
Gwon AR; Park JS; Arumugam TV; Kwon YK; Chan SL; Kim SH; Baik SH; Yang S; Yun YK; Choi Y; Kim S; Tang SC; Hyun DH; Cheng A; Dann CE; Bernier M; Lee J; Markesbery WR; Mattson MP; Jo DG
Aging Cell; 2012 Aug; 11(4):559-68. PubMed ID: 22404891
[TBL] [Abstract][Full Text] [Related]
33. Optimized TrkB Agonist Ameliorates Alzheimer's Disease Pathologies and Improves Cognitive Functions via Inhibiting Delta-Secretase.
Chen C; Ahn EH; Liu X; Wang ZH; Luo S; Liao J; Ye K
ACS Chem Neurosci; 2021 Jul; 12(13):2448-2461. PubMed ID: 34106682
[TBL] [Abstract][Full Text] [Related]
34. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro.
Mei Z; Zhang F; Tao L; Zheng W; Cao Y; Wang Z; Tang S; Le K; Chen S; Pi R; Liu P
Neurosci Lett; 2009 Mar; 452(2):90-5. PubMed ID: 19154776
[TBL] [Abstract][Full Text] [Related]
35. The Impact of UNC5C Genetic Variations on Neuroimaging in Alzheimer's Disease.
Sun JH; Wang HF; Zhu XC; Yu WJ; Tan CC; Jiang T; Tan MS; Tan L; Yu JT;
Mol Neurobiol; 2016 Dec; 53(10):6759-6767. PubMed ID: 26660111
[TBL] [Abstract][Full Text] [Related]
36. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
[TBL] [Abstract][Full Text] [Related]
37. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
[TBL] [Abstract][Full Text] [Related]
38. Familial Alzheimer's disease-associated presenilin 1 mutants promote γ-secretase cleavage of STIM1 to impair store-operated Ca2+ entry.
Tong BC; Lee CS; Cheng WH; Lai KO; Foskett JK; Cheung KH
Sci Signal; 2016 Sep; 9(444):ra89. PubMed ID: 27601731
[TBL] [Abstract][Full Text] [Related]
39. RAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity.
Fang F; Yu Q; Arancio O; Chen D; Gore SS; Yan SS; Yan SF
Hum Mol Genet; 2018 Mar; 27(6):1002-1014. PubMed ID: 29329433
[TBL] [Abstract][Full Text] [Related]
40. Investigation of TREM2, PLD3, and UNC5C variants in patients with Alzheimer's disease from mainland China.
Jiao B; Liu X; Tang B; Hou L; Zhou L; Zhang F; Zhou Y; Guo J; Yan X; Shen L
Neurobiol Aging; 2014 Oct; 35(10):2422.e9-2422.e11. PubMed ID: 24866402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]